In that chart, u notice there is NO "footnote" or "claimant" on Next Gen Mab compared to the other therapeutics which have those.. And all the "dot connecting" that has been done on Twitter. U can't help not think it's ENZC imo.. The NDA should drop very soon then if that scenerio plays out imo..
Market Data 
Markets 
